Enlicitide: A Curious(er) Macrocycle

Jun 13

Macrocyclic compounds lend themselves to interesting pharmacology. Merck's emerging PCSK9 inhibitor for "bad" cholesterol is no different. Will it retain its pole position or will it get leapfrogged?

Read →

Comments

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts

Dimension Research

Enlicitide: A Curious(er) Macrocycle